ACL Digital has acquired US-based contract research organisation (CRO) Symbiance to strengthen its position as a global end-to-end clinical research and data CRO solutions provider. The acquisition also enhances ACL Digital's life sciences portfolio by incorporating specialised expertise in pharmacovigilance, medical writing, biostatistics, data standardisation, clinical data management and statistical programming. ACL Digital CEO Ramandeep Singh said: "The acquisition aligns with our growth strategy, en ...